SEC Form 3 · accession 0001209191-15-087548
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BIOTIME INC
10% Owner
Period of report
Dec 30, 2015
Accepted (ET)
Dec 31, 2015 · 9:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par value | holding | — | — | — | 14,674,244 | D |
Table II — derivative securities
No Table II lines on this filing.